Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.47 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.47 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ALB | P02768 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL1750931 | 0.97 | CYP2C9 (0.47) | CYP3A4CYP2C9CYP1A2CYP2C19S1PR1 | |
| Ammonia Solution, Strong SCHEMBL29040632 | 0.97 | CYP3A4 (0.47) | CYP3A4CYP2C9CYP1A2CYP2C19S1PR1 | |
| SCHEMBL21394848 | 0.91 | S1PR1 (0.46) | CYP3A4CYP2C9CYP1A2CYP2C19S1PR1 | |
| SCHEMBL12591976 | 0.86 | S1PR1 (0.54) | CYP3A4S1PR1S1PR3CYP19A1ALDH1A1 | |
| SCHEMBL26329006 | 0.82 | CYP3A4 (0.47) | CYP3A4CYP2C9CYP1A2CYP2C19LOXL2 | |
| SCHEMBL21851278 | 0.82 | CYP3A4 (0.47) | CYP3A4CYP2C9CYP1A2CYP2C19LOXL2 | |
| SCHEMBL4662841 | 0.80 | CYP3A4 (0.45) | CYP3A4CYP2C9CYP1A2CYP2C19LOXL2 | |
| SCHEMBL8513064 | 0.80 | CYP3A4 (0.55) | CYP3A4CYP2C9CYP1A2CYP2C19LOXL2 | |
| SCHEMBL4690574 | 0.80 | CYP3A4 (0.45) | CYP3A4CYP2C9CYP1A2CYP2C19S1PR1 | |
| SCHEMBL11062127 | 0.80 | CYP3A4 (0.45) | CYP3A4CYP2C9CYP1A2CYP2C19S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 980 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1172878-B1 | Non-aqueous electrolytic solution and secondary battery containing same | MITSUBISHI CHEM CORP (JP) | 2011-06-22 | — | — | EP | claimed |
| US-20100154880-A1 | DYE-SENSITIZED SOLAR CELL, ANODE THEREOF, AND METHOD OF MANUFACTURING THE SAME | TAIWAN TEXTILE RESEARCH INSTITUTE (TW) | 2010-06-24 | — | — | US | claimed |
| US-20100154879-A1 | Dye-Sensitized Solar Cell, Photo-Sensitized Anode Electrode Thereof, and Method of Manufacturing the Same | TAIWAN TEXTILE RESEARCH INSTITUTE (TW) | 2010-06-24 | — | — | US | claimed |
| US-6906069-B1 | Diagnosis indicator; anticholesterol agents; antilipemic agents; antidiabtic agents | AMGEN INC. (US) | 2005-06-14 | — | — | US | claimed |
| US-6767671-B2 | STABILITY; HEAT RESISTANCE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-07-27 | — | — | US | claimed |
| US-20020025477-A1 | Non-aqueous electrolytic solution and secondary battery containing same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-02-28 | — | — | US | claimed |
| EP-1172878-A2 | Non-aqueous electrolytic solution and secondary battery containing same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-01-16 | — | — | EP | claimed |
| US-4005227-A | SUBSTITUTED PYRIDINE, SOLUBLE COFFEE | FIRMENICH & CIE (CH) | 1977-01-25 | — | — | US | claimed |
| WO-2025233901-A1 | ACTIVATORS OF PYRUVATE KINASE ISOFORM M2 AND METHODS FOR TREATING NEURODEGENERATIVE DISEASE | BIOHAVEN THERAPEUTICS LTD. (VG) | 2025-11-13 | — | — | WO | disclosed |
| EP-4318630-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS SECONDARY BATTERY | ASAHI CHEMICAL IND (JP) | 2025-10-22 | — | — | EP | disclosed |
| US-20250213735-A1 | NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. | 2025-07-03 | — | — | US | disclosed |
| CN-119751366-A | Dual-mechanism deep fungal infection resistant medicament | 上海友长医药有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119731596-A | Photosensitive resin composition, photosensitive resin sheet, cured product, method for producing cured product, semiconductor device, display device, and method for producing resin | 东丽株式会社 | 2025-03-28 | — | — | CN | disclosed |
| CN-119431313-A | Antifungal compound, preparation method and application thereof | 上海交通大学 | 2025-02-14 | — | — | CN | disclosed |
| US-3952026-A | FLAVOR ADDITIVE FOR FOODS AND BEVERAGES | FIRMENICH & CIE (CH) | 1976-04-20 | — | — | US | disclosed |
| US-3952024-A | FLAVOR ADDITIVE FOR FOODS AND BEVERAGES | FIRMENICH & CIE (CH) | 1976-04-20 | — | — | US | disclosed |
| US-3943260-A | TETRAHYDRO-THIO-PHEN-3-ONES | FIRMENICH & CIE (CH) | 1976-03-09 | — | — | US | disclosed |
| US-3931246-A | FURYLALKYL-THIOETHERS | FIRMENICH & CIE (CH) | 1976-01-06 | — | — | US | disclosed |
| US-3931166-A | FLAVORANTS | FIRMENICH & CIE (CH) | 1976-01-06 | — | — | US | disclosed |
| US-3931245-A | FURYLALKYLTHIOL CARBOXYLATES | FIRMENICH & CIE (CH) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250213735-A1 | NEUROPEPTIDE Y1 RECEPTOR (NPY1R) TARGETED THERAPEUTICS AND USES THEREOF | NPY1R, NPY2R, NPY4R | CYP3A4 4773/4885CYP2C9 4575/4885CYP1A2 4022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.